Back to Journals » Drug Design, Development and Therapy

Drug Design, Development and Therapy

ISSN: 1177-8881


Editor-in-Chief: Prof. Dr. Frank Boeckler

An international, peer-reviewed, open access journal that spans the spectrum of drug design and development through to clinical applications. The journal is characterized by the rapid reporting of application notes, reviews, original research and clinical studies in all therapeutic areas. Clinical outcomes, patient safety, and programs for the development and effective, safe, and sustained use of medicines will be a feature of the journal. 

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

Latest articles:

- 5 records -

Influences of Propofol, Ciprofol and Remimazolam on Dreaming During Anesthesia for Gastrointestinal Endoscopy: A Randomized Double-Blind Parallel-Design Trial

Zhou R, Fu L, Liu S, Gao S, Zhao Z, Jiang W, Liu L, Ren W, Xiang D, You X, Tang C, Zhou Y, Song Y, Xie J, Xie L, Yu R, Zhang X, Zhou D, Han J, Xia L, Xiong L

Drug Design, Development and Therapy 2024, 18:1907-1915

Published Date: 29 May 2024

Neurovascular Adverse Effects of Sars-Cov-2 Vaccination

Panos LD, Bargiotas P, Hadjigeorgiou G, Panos GD

Drug Design, Development and Therapy 2024, 18:1891-1905

Published Date: 30 May 2024

Shen’ge Formula Protects Cardiac Function in Rats with Pressure Overload-Induced Heart Failure

Qiu B, Qiao S, Shi X, Shen L, Deng B, Ma Z, Zhou D, Wei Y

Drug Design, Development and Therapy 2024, 18:1875-1890

Published Date: 30 May 2024


Read more articles